Bachem Holding AG (Bachem Holding AG) Research & Development : $12.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Bachem Holding AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bachem Holding AG's Research & Development for the six months ended in Dec. 2023 was $6.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $12.5 Mil.

Bachem Holding AG Research & Development Historical Data

The historical data trend for Bachem Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG Research & Development Chart

Bachem Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

1.68

3.31

4.14

7.73

12.77

Bachem Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															2.10	2.20	5.44	6.10	6.41

Bachem Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $12.5 Mil.

Bachem Holding AG (OTCPK:BCHMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bachem Holding AG Research & Development Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bachem Holding AG (Bachem Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (OTCPK:BCHMF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BANBz:UK BANB:Switzerland

Address

Hauptstrasse 144, Bubendorf, CHE, 4416

Website

https://www.bachem.com

Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Bachem Holding AG (Bachem Holding AG) Headlines

No Headlines